obesity drug news today glp-1 september 29 2025 Use of diabetes and anti-obesity drugs surges nationwide Alarming rise in weight loss

Side effect profiles differ patients may tolerate semaglutide better

According to the Cleveland Clinic, these medications help limit blood sugar by binding to GLP receptors to trigger the effects and inhabit the role of the GLP-1 hormone

In this study, participants taking orforglipron experienced an average A1C reduction of 2.1% and an average weight loss of 10.1 kilograms at 26 weeks, which was significantly greater than those in the placebo and dulaglutide groups

NEJM, 2022

Nauck MA, Meier JJ, Cavender MA, El AbdAziz M, Drucker DJ

Generally speaking, your risk of developing erectile problems are likely less when taking a GLP-1, especially after your body builds normal tolerance